1Brazier, J, Ratcliffe, J, Salamon, JTA. Measuring and valuing health benefits for economic evaluation. Oxford University Press, 2016.
2Dakin, H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes 2013; 11: 151.
4Lovibond, SH, Lovibond, PF. Manual for the Depression Anxiety Stress Scales. Psychology Foundation, 1995.
5Kessler, RC, Barker, PR, Colpe, LJ, Epstein, JF, Gfroerer, JC, Hiripi, E, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003; 60(2): 184–9.
6Mihalopoulos, C, Chen, G, Iezzi, A, Khan, MA, Richardson, J. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry 2014; 205(5): 390–7.
7Wisloff, T, Hagen, G, Hamidi, V, Movik, E, Klemp, M, Olsen, JA. Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010. Pharmacoeconomics 2014; 32(4): 367–75.
8National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. National Institute for Health and Care Excellence, 2013 (https://www.nice.org.uk/process/pmg9/).
9van Hout, B, Janssen, MF, Feng, YS, Kohlmann, T, Busschbach, J, Golicki, D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3 L value sets. Value Health 2012; 15: 708–15.
10Dolan, P. Modeling valuations for EuroQol health states. Med Care 1997; 35(11): 1095–108.
11Augustovski, F, Rey-Ares, L, Irazola, V, Garay, OU, Gianneo, O, Fernandez, G, et al. An EQ-5D-5L value set based on Uruguayan population preferences. Qual Life Res 2015; 25: 323–33.
12Kim, S-H, Ahn, J, Ock, M, Shin, S, Park, J, Luo, N, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res 2016; 25(7): 1845–52.
13Luo, N, Liu, G, Li, M, Guan, H, Jin, X, Rand-Hendriksen, K. Estimating an EQ-5D-5L value set for China. Value Health 2017; 20: 662–9.
14Ramos-Goni, JM, Pinto-Prades, JL, Oppe, M, Cabases, JM, Serrano-Aguilar, P, Rivero-Arias, O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care 2017; 55: e51–8.
15Versteegh, MM, Vermeulen, KM, Evers, SMAA, de Wit, GA, Prenger, R, Stolk, EA. Dutch tariff for the five-level version of EQ-5D. Value Health 2016; 19: 343–52.
16Xie, F, Pullenayegum, E, Gaebel, K, Bansback, N, Bryan, S, Ohinmaa, A, et al. A time trade-off-derived value set of the EQ-5D-5L for Canada. Med Care 2016; 54: 98–105.
17Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, van Hout, B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018; 27: 7–22.
18Shiroiwa, T, Ikeda, S, Noto, S, Igarashi, A, Fukuda, T, Saito, S, et al. Comparison of value set based on DCE and/or TTO data: scoring for EQ-5D-5L health states in Japan. Value Health 2016; 19(5): 648–54.
19Zhao, Y, Li, SP, Liu, L, Zhang, JL, Chen, G. Does the choice of tariff matter?: A comparison of EQ-5D-5L utility scores using Chinese, UK, and Japanese tariffs on patients with psoriasis vulgaris in Central South China. Medicine (Baltimore) 2017; 96(34): e7840.
20Petrou, S, Rivero-Arias, O, Dakin, H, Longworth, L, Oppe, M, Froud, R, et al. Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement. Pharmacoeconomics 2015; 33(10): 985–91.
22Herdman, M, Gudex, C, Lloyd, A, Janssen, M, Kind, P, Parkin, D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20(10): 1727–36.
23Russell, DW. In search of underlying dimensions: the use (and abuse) of factor analysis in personality and social psychology bulletin. Pers Soc Psychol Bull 2002; 28(12): 1629–46.
24Antony, MM, Bieling, PJ, Cox, BJ, Enns, MW, Swinson, RP. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess 1998; 10(2): 176–81.
25Fabrigar, LR, Wegener, DT, MacCallum, RC, Strahan, EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods 1999; 4(3): 272–99.
26Brazier, JE, Yang, Y, Tsuchiya, A, Rowen, DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010; 11: 215–25.
27Smithson, M, Verkuilen, J. A better lemon squeezer? Maximum-likelihood regression with beta distributed dependent variables. Psychol Methods 2006; 11: 54–71.
28Khan, I, Morris, S, Pashayan, N, Matata, B, Bashir, Z, Maguirre, J. Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients. Health Qual Life Outcomes 2016; 14: 60.
29Papke, LE, Wooldridge, JM. Econometric methods for fractional response variables with an application to 401(k) plan participation rates. J Appl Econom 1996; 11(6): 619–32.
30Susanti, Y, Sri Sulistijowai, H, Pratiwi, H, Liana, T. M estimation, S estimation, and MM estimation in robust regression. Int J Pure Appl Mathem 2014; 91(3): 349–60.
31Ayinde, K, Lukman, AF, Arowolo, O. Robust regression diagnostics of influential observations in linear regression model. Open J Stat 2015; 5(4): 272–83.
32Powell, JL. Least absolute deviations estimation for the censored regression model. Journal of Econometrics. 1984; 25(3): 303–25.
33Versteegh, MM, Leunis, A, Luime, JJ, Boggild, M, Uyl-de Groot, CA, Stolk, EA. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Med Decis Making 2012; 32: 554–68.
34Sullivan, PW, Ghushchyan, V. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Med Decis Making 2006; 26(4): 401–9.
35Lindkvist, M, Feldman, I. Assessing outcomes for cost-utility analysis in mental health interventions: mapping mental health specific outcome measure GHQ-12 onto EQ-5D-3L. Health Qual Life Outcomes 2016; 14(1): 134.
36Brazier, J, Connell, J, Papaioannou, D, Mukuria, M, Mulhern, B, Peasgood, T, et al. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess 2014; 18(34).
37Olsen, JA, Lamu, A, Cairns, J. In search of a common currency: a comparison of seven EQ-5D-5L value sets. Health Econ 2018; 27(1): 39–49.
38Brazier, J. Is the EQ-5D fit for purpose in mental health? Br J Psychiatry 2010; 197(5): 348–9.